
    
      This is a phase III, open label, randomized, controlled, multicenter study with two parallel
      groups of patients.

      TizasprayÂ® 0.5 mg (a new pharmaceutical form, liquid nasal spray solution), is proposed in
      this trial as a ready to use treatment for short term therapy of painful muscle spasms as the
      acute low back pain.
    
  